AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32590653 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia with lidocaine and tourniquet
Number of subjects: 102
Study 35635754 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet use
Number of subjects: 354
Study 35635754 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media use
Number of subjects: 354
Study 35635754 — intervention group
Group type: EXPERIMENTAL
Intervention: Health information search
Number of subjects: 354
Study 35635754 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media use by gender
Number of subjects: 354
Study 35635754 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media use by age
Number of subjects: 354
Study 35635754 — intervention group
Group type: EXPERIMENTAL
Intervention: Health risk factors and information search
Number of subjects: 354
Study 36411403 — intervention group
Group type: EXPERIMENTAL
Intervention: MomsTalkShots (educational videos tailored to vaccine intentions, attitudes, and demographics)
Number of subjects: 2087
Study 36411403 — intervention group
Group type: EXPERIMENTAL
Intervention: MomsTalkShots
Number of subjects: 2087
Study 35194698 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth delivered Couples' HIV counseling and testing (CHTC) session with two home HIV-testing kits
Number of subjects: 424
Study 35194698 — intervention group
Group type: COMPARATOR
Intervention: Control arm with two home HIV-testing kits
Number of subjects: 424
Study 33740765 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.0-mm-diameter titanium (Ti) rods
Number of subjects: 69
Study 33740765 — intervention group
Group type: COMPARATOR
Intervention: 6.0-mm-diameter cobalt-chromium (CoCr) rods
Number of subjects: 69
Study 33403525 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified radical mastectomy (MRM)
Number of subjects: 97
Study 33403525 — intervention group
Group type: COMPARATOR
Intervention: No surgery (non-MRM)
Number of subjects: 97
Study 33403525 — intervention group
Group type: EXPERIMENTAL
Intervention: MRM
Number of subjects: 97
Study 33403525 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial/complete response of distant disease to chemotherapy
Number of subjects: 97
Study 36919444 — intervention group
Group type: EXPERIMENTAL
Intervention: Active repetitive transcranial magnetic stimulation treatment for 4 weeks
Number of subjects: 60
Study 36919444 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 60
Study 36919444 — intervention group
Group type: COMPARATOR
Intervention: Good sleeper controls
Number of subjects: 60
Study 34753433 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST)
Number of subjects: 15
Study 34490741 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP infusion (4 pmol/kg/min)
Number of subjects: 10
Study 34490741 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion (saline)
Number of subjects: 10
Study 33002463 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 54
Study 33002463 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular pacing (RVP)
Number of subjects: 54
Study 35465692 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT) plus rescue medication (Group A)
Number of subjects: 56
Study 35465692 — intervention group
Group type: COMPARATOR
Intervention: Rescue medication alone (Group B)
Number of subjects: 56
Study 32687474 — intervention group
Group type: EXPERIMENTAL
Intervention: Stay Strong+Coaching
Number of subjects: 357
Study 32687474 — intervention group
Group type: COMPARATOR
Intervention: Stay Strong
Number of subjects: 357
Study 34196498 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg once daily
Number of subjects: 187
Study 34196498 — intervention group
Group type: COMPARATOR
Intervention: Placebo (switched to Upadacitinib at week 14)
Number of subjects: 187
Study 32445228 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab
Number of subjects: 3465
Study 32445228 — intervention group
Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 3465
Study 32445228 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab and Alendronate
Number of subjects: 3465
Study 32567234 — intervention group
Group type: EXPERIMENTAL
Intervention: NPWT with instillation of polyhexamethylene biguanide solution
Number of subjects: 132
Study 32567234 — intervention group
Group type: COMPARATOR
Intervention: Standard NPWT without instillation therapy
Number of subjects: 132
Study 32567234 — intervention group
Group type: EXPERIMENTAL
Intervention: NPWT plus instillation
Number of subjects: 132
Study 32567234 — intervention group
Group type: COMPARATOR
Intervention: Standard NPWT
Number of subjects: 132
Study 32567234 — intervention group
Group type: COMPARATOR
Intervention: NPWT with instillation and standard NPWT
Number of subjects: 132
Study 33949243 — intervention group
Group type: EXPERIMENTAL
Intervention: CHoBI7 mobile health program
Number of subjects: 1468
Study 33887631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via in situ hybridization (ISH) technique
Number of subjects: 270
Study 33887631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in men
Number of subjects: 270
Study 33887631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in women
Number of subjects: 270
Study 33887631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in cases under 40 years
Number of subjects: 270
Study 33887631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in cases over 40 years
Number of subjects: 270
Study 33887631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in patients with infectious indications for tonsillectomy
Number of subjects: 270
Study 33887631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in patients with non-infectious indications for tonsillectomy
Number of subjects: 270
Study 33887631 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate analysis of factors associated with high-risk HPV positivity
Number of subjects: 270
Study 35331714 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a‐tDCS) over the left‐oPFC
Number of subjects: 19
Study 35331714 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation over the left‐oPFC
Number of subjects: 19
Study 34606551 — intervention group
Group type: EXPERIMENTAL
Intervention: 165 mg GHES with 387 mg GTC
Number of subjects: 36
Study 32439492 — intervention group
Group type: EXPERIMENTAL
Intervention: Parvovirus B19 DNA positive donations
Number of subjects: 1053
Study 32439492 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of anti-B19 IgM and IgG antibodies
Number of subjects: 1053
Study 35945550 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-SMART
Number of subjects: 4605
Study 35945550 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-STAT2
Number of subjects: 4605
Study 35945550 — intervention group
Group type: EXPERIMENTAL
Intervention: Both studies
Number of subjects: 4605
Study 33612490 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention using a comprehensive child safety and injury prevention module taught periodically by teachers.
Number of subjects: 1100
Study 33612490 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 1100
Study 32780794 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based alternative meat
Number of subjects: 36
Study 32780794 — intervention group
Group type: COMPARATOR
Intervention: Animal meat
Number of subjects: 36
Study 33846990 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam (MLX) - IM administration
Number of subjects: 72
Study 33846990 — intervention group
Group type: COMPARATOR
Intervention: Meloxicam (MLX) - Oral administration
Number of subjects: 72
Study 33846990 — intervention group
Group type: EXPERIMENTAL
Intervention: Carprofen (CRP) - IM administration
Number of subjects: 72
Study 33846990 — intervention group
Group type: COMPARATOR
Intervention: Carprofen (CRP) - Oral administration
Number of subjects: 72
Study 33846990 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolfenamic acid (TA) - IM administration
Number of subjects: 72
Study 33846990 — intervention group
Group type: COMPARATOR
Intervention: Tolfenamic acid (TA) - Oral administration
Number of subjects: 72
Study 33120826 — intervention group
Group type: EXPERIMENTAL
Intervention: CNP group, treated with CNP plan
Number of subjects: 100
Study 33120826 — intervention group
Group type: COMPARATOR
Intervention: Control group, given normal routine care
Number of subjects: 100
Study 32488368 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanofracture group (footprint prepared with nanofractures, 1 mm wide, 9 mm deep microfractures)
Number of subjects: 69
Study 32488368 — intervention group
Group type: COMPARATOR
Intervention: Control group (arthroscopic supraspinatus repair without nanofractures)
Number of subjects: 69
Study 32488368 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanofracture group
Number of subjects: 69
Study 32488368 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 32478816 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion MRI (index test)
Number of subjects: 872
Study 32478816 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion MRI (index test) by 1 neuroradiologist
Number of subjects: 872
Study 32478816 — intervention group
Group type: COMPARATOR
Intervention: Current MRI criteria
Number of subjects: 872
Study 32478816 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion MRI (index test) for 88 patients
Number of subjects: 872
Study 32478816 — intervention group
Group type: COMPARATOR
Intervention: Improved RT-QuIC
Number of subjects: 872
Study 32478816 — intervention group
Group type: COMPARATOR
Intervention: 14-3-3 and tau CSF tests
Number of subjects: 872
Study 34255049 — intervention group
Group type: EXPERIMENTAL
Intervention: WMP+Rx (Weight Management Program combined with Antiobesity Medication)
Number of subjects: 200
Study 34255049 — intervention group
Group type: COMPARATOR
Intervention: WMP (Weight Management Program alone)
Number of subjects: 200
Study 34255049 — intervention group
Group type: EXPERIMENTAL
Intervention: WMP+Rx
Number of subjects: 200
Study 34255049 — intervention group
Group type: COMPARATOR
Intervention: WMP
Number of subjects: 200
Study 33060734 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary sodium (UNa)
Number of subjects: 322154
Study 33060734 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 322154
Study 35690665 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BJ)
Number of subjects: 11
Study 35690665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 34487459 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback training
Number of subjects: 50
Study 32161969 — intervention group
Group type: EXPERIMENTAL
Intervention: gender‐neutral HPV16/18 vaccination
Number of subjects: 11662
Study 32161969 — intervention group
Group type: COMPARATOR
Intervention: girls‐only HPV16/18 vaccination
Number of subjects: 11662
Study 32161969 — intervention group
Group type: COMPARATOR
Intervention: hepatitis B virus vaccination
Number of subjects: 11662
Study 35669487 — intervention group
Group type: EXPERIMENTAL
Intervention: 50g prune (50g prune/day; n = 79)
Number of subjects: 235
Study 35669487 — intervention group
Group type: EXPERIMENTAL
Intervention: 100g prune (100g prune/day; n = 78)
Number of subjects: 235
Study 35669487 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (1200 mg calcium + 800 IU vitamin D3 daily)
Number of subjects: 235
Study 33218548 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT)
Number of subjects: 28
Study 33218548 — intervention group
Group type: COMPARATOR
Intervention: Non-tape
Number of subjects: 28
Study 33944698 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming using the Playpulse platform for a minimum of 45 minutes twice weekly for eight weeks
Number of subjects: 30
Study 33944698 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 33419742 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT)
Number of subjects: 82
Study 33419742 — intervention group
Group type: COMPARATOR
Intervention: Low-flow nasal oxygen (LFO)
Number of subjects: 82
Study 33461754 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 100 μg carbetocin
Number of subjects: 138
Study 33461754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 32532328 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar spinal manipulation
Number of subjects: 100
Study 32532328 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 100
Study 34598935 — intervention group
Group type: EXPERIMENTAL
Intervention: Champ4Life programme (12 educational sessions, nutrition appointment with a caloric deficit of 300-500 kcal/day)
Number of subjects: 94
Study 34598935 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 94
Study 32859143 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music (20-min track compilation)
Number of subjects: 18
Study 32859143 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (5 sets of 10 repetitions at 75% of 1 repetition maximum)
Number of subjects: 18
Study 32859143 — intervention group
Group type: COMPARATOR
Intervention: Sham control (seated rest)
Number of subjects: 18
Study 32859143 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise with music
Number of subjects: 18
Study 35708222 — intervention group
Group type: EXPERIMENTAL
Intervention: ODTR SuperLearner
Number of subjects: 0
Study 35708222 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 33300757 — intervention group
Group type: EXPERIMENTAL
Intervention: R24‐S2
Number of subjects: 10
Study 33300757 — intervention group
Group type: EXPERIMENTAL
Intervention: All sessions
Number of subjects: 10
Study 35725127 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33617303 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar Androgen Therapy (BAT)
Number of subjects: 195
Study 33617303 — intervention group
Group type: COMPARATOR
Intervention: Enzalutamide
Number of subjects: 195
Study 33617303 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar Androgen Therapy (BAT)→Enzalutamide
Number of subjects: 195
Study 33617303 — intervention group
Group type: COMPARATOR
Intervention: Enzalutamide→Bipolar Androgen Therapy (BAT)
Number of subjects: 195
Study 33617303 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT→Enzalutamide
Number of subjects: 195
Study 33617303 — intervention group
Group type: COMPARATOR
Intervention: Enzalutamide→BAT
Number of subjects: 195
Study 33333956 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemically synthesized peptide
Number of subjects: 0
Study 33333956 — intervention group
Group type: COMPARATOR
Intervention: Randomized sequence peptides
Number of subjects: 0
Study 35179548 — intervention group
Group type: EXPERIMENTAL
Intervention: TK-98 (BCAAs)
Number of subjects: 47
Study 35179548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 32914169 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (four sessions including assessment of perceived needs, problem-solving treatment skills, and psycho-education)
Number of subjects: 59
Study 32914169 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 59
Study 33242637 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at three real acupoints over two consecutive days
Number of subjects: 90
Study 33242637 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure points
Number of subjects: 90
Study 33242637 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at three real acupoints
Number of subjects: 90
Study 35266835 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation at home (RAH)
Number of subjects: 10
Study 35266835 — intervention group
Group type: COMPARATOR
Intervention: Traditional skilled nursing facility (SNF)
Number of subjects: 10
Study 32562377 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 23
Study 32562377 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% O2
Number of subjects: 23
Study 32562377 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin + 40% O2
Number of subjects: 23
Study 32562377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 35715013 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (n=31)
Number of subjects: 64
Study 35715013 — intervention group
Group type: COMPARATOR
Intervention: Control (n=33)
Number of subjects: 64
Study 34906235 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDT)
Number of subjects: 195
Study 32324888 — intervention group
Group type: EXPERIMENTAL
Intervention: Itacitinib 200 mg once daily plus corticosteroids
Number of subjects: 29
Study 32324888 — intervention group
Group type: EXPERIMENTAL
Intervention: Itacitinib 300 mg once daily plus corticosteroids
Number of subjects: 29
Study 32324888 — intervention group
Group type: EXPERIMENTAL
Intervention: Itacitinib (both doses)
Number of subjects: 29
Study 33272091 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin infusion (maximum of 20,000 units for 24 hours)
Number of subjects: 26
Study 33272091 — intervention group
Group type: COMPARATOR
Intervention: No heparin infusion
Number of subjects: 26
Study 33272091 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin treatment
Number of subjects: 26
Study 33272091 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin infusion
Number of subjects: 26
Study 33272091 — intervention group
Group type: COMPARATOR
Intervention: Heparin infusion vs No heparin infusion
Number of subjects: 26
Study 35705501 — intervention group
Group type: EXPERIMENTAL
Intervention: Cenobamate (target dose 300 mg/day; min/max 50/400 mg/day)
Number of subjects: 360
Study 32660270 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic Broström (AB) technique
Number of subjects: 39
Study 32660270 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic all‐inside ligament repair (AI) technique
Number of subjects: 39
Study 34168648 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-drug empiric standard TB treatment
Number of subjects: 55
Study 34168648 — intervention group
Group type: COMPARATOR
Intervention: Control group (32 controls)
Number of subjects: 55
Study 34168648 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision-tree algorithm
Number of subjects: 55
Study 33252690 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet (n = 122)
Number of subjects: 244
Study 33252690 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 122)
Number of subjects: 244
Study 35667733 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 160
Study 35667733 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture (SEA)
Number of subjects: 160
Study 33081449 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine at a dose of 2000 mg per day for 60 days
Number of subjects: 20
Study 33081449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 33128535 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung rehabilitation therapy in combination with routine nursing (observation group)
Number of subjects: 58
Study 33128535 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (control group)
Number of subjects: 58
Study 33128535 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung rehabilitation therapy (observation group)
Number of subjects: 58
Study 34265434 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 554
Study 34265434 — intervention group
Group type: COMPARATOR
Intervention: Platinum-based chemotherapy
Number of subjects: 554
Study 34325885 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone (100 mg-200 mg)
Number of subjects: 140
Study 34325885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 35463059 — intervention group
Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (2 g/day)
Number of subjects: 46
Study 35463059 — intervention group
Group type: COMPARATOR
Intervention: Placebo (paraffin oil)
Number of subjects: 46
Study 33288923 — intervention group
Group type: EXPERIMENTAL
Intervention: Chimeric hemagglutinin-based vaccines (live-attenuated followed by AS03-adjuvanted inactivated vaccine)
Number of subjects: 66
Study 33288923 — intervention group
Group type: EXPERIMENTAL
Intervention: Chimeric hemagglutinin-based vaccines (live-attenuated followed by inactivated vaccine)
Number of subjects: 66
Study 33288923 — intervention group
Group type: EXPERIMENTAL
Intervention: Chimeric hemagglutinin-based vaccines (twice AS03-adjuvanted inactivated vaccine)
Number of subjects: 66
Study 33288923 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intranasal followed by intramuscular)
Number of subjects: 66
Study 33288923 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice intramuscular)
Number of subjects: 66
Study 35107519 — intervention group
Group type: EXPERIMENTAL
Intervention: Açaí Group (100mg of açaí extract)
Number of subjects: 30
Study 35107519 — intervention group
Group type: COMPARATOR
Intervention: Placebo Group (without active)
Number of subjects: 30
Study 35107519 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Açaí and Placebo)
Number of subjects: 30
Study 32283820 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaging Training (IMG)
Number of subjects: 38
Study 32283820 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 38
Study 35049127 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention (cognitive training, physical activity, nutrition, omega-3 fatty acids)
Number of subjects: 749
Study 35049127 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of intervention
Number of subjects: 749
Study 35049127 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal dose of intervention
Number of subjects: 749
Study 32392231 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based cardiac rehabilitation (43% participation rate)
Number of subjects: 19136
Study 32392231 — intervention group
Group type: COMPARATOR
Intervention: Non-attenders of exercise-based cardiac rehabilitation
Number of subjects: 19136